MedTrace Logo

Extended Platelet Rich Fibrin or Hyaluronate Enriched Xenografts for Horizontal Ridge Augmentation Via Subperiosteal Tunneling

NCT07412535 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2026-02-17

No results posted yet for this study

Summary

Extended platelet rich fibrin or hyaluronate enriched xenografts will be used for horizontal maxillary ridge augmentation via subperiosteal tunneling to allow placement of dental implants six months later.

Conditions

  • Dental Implant

Interventions

COMBINATION_PRODUCT

bovine bone mixed with hyaluronate

cerabone plus will be inserted as a graft material via subperiosteal tunneling of thin maxilla

COMBINATION_PRODUCT

bovine bone mixed with E-PEF

bovine bone mixed with E-PEF will be inserted as a graft material via subperiosteal tunneling of thin maxilla

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2024-10-01
Completion
2025-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07412535 on ClinicalTrials.gov